NeuroOne Medical Technologies Corporation
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -151.8% | -151.8% | -125.3% |
| FY2022 | -104.1% | -104.1% | -78.0% |
| FY2023 | -189.8% | -189.8% | -146.5% |
| FY2024 | -1,498.5% | -1,498.5% | -229.4% |
| FY2025 | -51.0% | -51.0% | -33.4% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -151.8% | -151.8% | -125.3% |
| FY2022 | -104.1% | -104.1% | -78.0% |
| FY2023 | -189.8% | -189.8% | -146.5% |
| FY2024 | -1,498.5% | -1,498.5% | -229.4% |
| FY2025 | -51.0% | -51.0% | -33.4% |